NEW YORK (360Dx) –  T2 Biosystems has joined the Antimicrobials Working Group as its first diagnostics member. T2 is the fourteenth company to join the group, which is focused on combatting drug-resistant infections and developing "life-saving innovations." T2 sells the T2Dx Instrument and the T2Candida Panel, both of which have been cleared by the US Food and Drug Administration. The firm is currently conducting clinical studies on its T2Bacteria panel for detection of bacterial sepsis.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.